Amgen will buy the psoriasis pill Otezla from Celgene, which is selling it to remove an obstacle from its planned merger with Bristol-Myers Squibb.
https://www.statnews.com/2019/08/26/celgene-psoriasis-pill-amgen-bristol-merger/
STAT
This site is not involved in the creation of this post.



